If you have suffered from cancer after taking Zantac, you may be eligible to join the lawsuit against the makers of Zantac and Ranitidine.

Product recall

On April 1, 2020, the U.S. Food and Drug Administration (FDA)  announced it was requesting manufacturers to immediately withdraw all prescription and over-the-counter (OTC) ranitidine products from the marketplace. The FDA determined that the product contains an impurity called N-Nitrosodimethylamine (NDMA), which is a probable human carcinogen. The original owners of the Zantac brand, Sanofi, finally withdrew the product in October 2019.

Potent carcinogen

The recall came after the Food and Drug Administration (FDA) found NDMA in Zantac. NDMA has been found to be a potent carcinogen and is particularly linked to stomach and bladder cancers.

On the same day the FDA published its first warning, a lawsuit was filed against Sanofi in Florida by a man who had contracted breast cancer (extremely rare in men) after using Zantac on a chronic basis over the course of nine years. Several other plaintiffs have since come forward, saying that the manufacturer had an obligation to know about the potential for contamination by such harmful chemicals, and should have never allowed the product to be distributed. 

Most of the plaintiffs have suffered or are suffering from digestive tract related-cancers (stomach, bladder, esophageal, etc.), although other kinds of cancers have also been reported. 

Join the Zantac lawsuit against Sanofi

Eric Mausner Law wants to help all Florida residents who have ingested Zantac (name brand or prescription Ranitidine) and then have been diagnosed with cancer. If you or a loved one has consumed Zantac and developed cancer, please contact our law firm to see if you are eligible to join the Zantac lawsuit against Sanofi and other defendants. Please contact us at 305-800-8678 for more information.